Safety Consulting

Med-E.R.R.S. is available to perform consultative services related to a variety of medication safety-related issues.  From the trademark safety evaluation standpoint, such issues may include opinions on complex nomenclature issues, for instance, specific name pair confusion (side-by-side comparison), trademark modifiers (i.e., suffixes), trademark rejections by regulatory bodies (FDA, EMEA, etc.), and the use of more than one trademark for the same chemical entity.

Other consultative services include but are not limited to evaluation of educational material from the medication safety (error prevention) standpoint as well as the facilitation of focus group or advisory board meetings to discuss a medication safety-related issue for a particular product.